Colon to Rectum

Gastroenterology. 2022;163(6):1547–54.e5

Agrawal M, Christensen HS, Bøgsted M, Colombel JF, Jess T, Allin KH

The rising burden of inflammatory bowel disease in Denmark over 2 decades: A nationwide cohort study


Background and aims: Shifts in epidemiological stages of inflammatory bowel disease (IBD) carry implications toward understanding IBD etiology and managing clinical care. The authors conducted a temporal analysis of the epidemiology of IBD between 1995 and 2016 in the Danish nationwide cohort.
Methods: They used the Danish registers to obtain data on demographics and IBD-related outpatient and inpatient contacts between 1995 and 2016. IBD diagnosis was defined as having ≥ 2 registrations related to Crohn’s disease (CD) or ulcerative colitis (UC) within a 2-year period. They estimated overall and annual incidence rates and prevalence of CD and UC standardized with respect to age and sex.
Results: A total of 47,830 individuals met the criteria for IBD diagnosis, of which 33% were diagnosed with CD and 67% with UC. Between 1995 and 2016, the incidence rate per 100,000 person-years rose from 9.1 (95% confidence interval [CI]: 8.3–10.0) to 17.8 (95% CI: 16.8–19.0) for CD, and from 21.0 (95% CI: 19.8–22.3) to 28.4 (95% CI: 27.0–29.8) for UC. The highest increase in CD and UC incidence rates occurred in children and young adults, respectively. The prevalence of IBD doubled from 1995 to 2016; the greatest increase (2.5-fold) was in UC prevalence among individuals aged > 40 years. During this period, the median age of the IBD population increased by 6 to 7 years.

Conclusions: In Denmark, the incidence and prevalence of inflammatory bowel disease (IBD) have increased during the last 2 decades. The IBD population is shifting toward an older age. These findings have implications towards understanding environmental shifts as well as preparing health care systems for an aging IBD population.

M. Agrawal, M.D., Assistant Professor of Medicine, The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA,
E-Mail: manasi.agrawal@mountsinai.org

DOI: DOI: 10.1053/j.gastro.2022.07.062

Back to overview

this could be of interest:

Efficacy of fecal microbiota transplantation for patients with irritable bowel syndrome at 3 years after transplantation

Gastroenterology. 2022;163(4):982–94.e14

Effect of colonoscopy screening on risks of colorectal cancer and related death

N Engl J Med. 2022;387(17):1547–56

More articles on the topic